Skip to main content
Real-world data support the continued use of second-line targeted therapies in CLL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Real-world data support the continued use of second-line targeted therapies in CLL
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Biologic Therapy
0
1
Targeted Cancer Therapy
0
0.87
Prognosis
0
0.85
Antineoplastic Drug
0
0.35
Monoclonal Antibody
0
0.35
Refractory
0
0.17
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Edit Tags